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Background: Sarcoidosis is a systemic disease characterized by the formation of noncaseating granulomas in
various tissues. Cutaneous involvement occurs in 20 to 35 percent of the patients and may be the initial
manifestation of the disease. Our study was performed to discriminate the clinical, laboratory, and prognostic
differences between patients with specific and nonspecific cutaneous involvement. The second aim was to asses
the diagnostic usefulness of punch biopsy in sarcoidosis.
Methods: The clinical, laboratory, pathological features, and skin biopsy results of 120 patients with cutaneous
sarcoidosis were evaluated. The patients fulfilled clinical, radiologic or both features of sarcoidosis supported by the
histopathologic evidence of noncaseating granulomas.
Skin involvement was the initial finding in 30% of the patients. Erythema nodosum and lupus pernio were the most
common skin lesions. Almost all of the patients with LP were either stage 0 or 1. Respiratory symptoms occurred in
72.2% of the patients with specific skin involvement. BronchoalveolarLavage (BAL) lymphocytosis, high ratio of CD4/
CD8 and elevated serum Angiotensin Converting Enzyme (ACE) were more frequent in patients with specific
cutaneous lesions. The frequency of progressive disease was significantly higher in this group. Punch skin biopsy
was diagnostic in 81.6% of the patients with a complication rate of 4%.
Conclusions: Specific cutaneous lesions along with BAL lymphocytosis, high CD4/CD8 ratio and elevated serum
ACE levels may be predictors of progressive disease in sarcoidosis. Punch biopsy is a simple technique with a high
diagnostic yield and a low complication rate for cutaneous sarcoidosis.
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Sarcoidosis is a multi-system disease of unknown etiology
that has a wide variety of clinical manifestations and fre-
quently, an unpredictable course. It involves mainly the
lungs, mediastinal and peripheral lymph nodes, skin, liver,
spleen, eyes and parotid glands. Less frequently, but usu-
ally severe, manifestations also occur in the central ner-
vous system, heart, upper respiratory tract and bones.
Because lesions can exhibit many different morphologies,
cutaneous sarcoidosis is known as one of the great imita-
tors in dermatology [1-3].
The prevalence of a particular type of cutaneous lesion
varies among races as well as individual cases. The* Correspondence: tetikkurt@gmail.com
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reproduction in any medium, provided the orfrequency of specific cutaneous involvement in sarcoid-
osis ranges from 9% to 37% [4,5]. Although different
series report variable incidences of skin involvement
during the course of the disease, nearly a quarter of sar-
coidosis patients have occurrence of skin lesions [6,7].
Cutaneous involvement in sarcoidosis may occur at any
stage of the disease but most often present at the onset
and the patients are often seen initially by a dermatolo-
gist [2,3]. Different skin lesions associated with sarcoid-
osis have been reported. They are divided into two
groups as: specific skin lesions where histological exam-
ination shows the typical sarcoid granulomas, and non-
specific skin lesions. Specific lesions are lupus pernio
(LP), infiltrated plaques, maculopapular eruptions, sub-
cutaneous nodules and scars, and rare morphologies
such as alopecia, ulcers, hypopigmented patches, and
ichthyosis. Despite the clinical importance of scarral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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overlooked because the lesions are usually small and
asymptomatic. Erythema nodosum is the most frequent
nonspecific skin lesion in sarcoidosis [2,6,7].
We retrospectively analyzed the clinical and dermato-
logical features of sarcoidosis at our center. The aim of
our study was to determine the correlation between spe-
cific or nonspecific skin lesions, involvement of other or-
gans, clinical findings, disease stages and to establish the
diagnostic usefulness of punch biopsy for cutaneous
sarcoidosis.
Methods
One hundred and twenty patients attending our center
between September 1966 and January 2011 were in-
cluded in the study. The patients fulfilled clinical, radio-
logic or both features of sarcoidosis supported by the
histopathologic evidence of noncaseating granulomas.
The skin changes reported by the patients and noted in
the medical records were taken into account. All pa-
tients had specific or nonspecific skin lesions confirmed
by punch, or wedge biopsy. The medical charts were
used to obtain data about patient’s age, sex, radiologic
stage, laboratory findings, pulmonary function tests,
bronchoalveolar lavage (BAL) and histopathologic re-
sults. Sputum or bronchial lavage culture was done to
exclude infection.
Central nervous system involvement was considered
to exist if a lesion was confirmed by computed tomog-
raphy (CT) or magnetic resonance imaging (MRI) and
diagnosed by a consultant neurologist. For evidence of
ocular sarcoidosis all patients were screened by an
opthalmologist. Abnormal liver function tests, hypercal-
cemia and hypercalcuria were considered to be present
if they were above the normal range. Spirometry was
performed according to the ATS/ERS recommendations
with a body plethysmograph unit (Zan 500, Messgeraete,
Oberthulba, Germany). DLCO was measured with the
single-breath technique and was adjusted for alveolar
ventilation (VA). The evidence of restrictive (reduced
TLC or FVC and normal or high FEV1/FVC), obstruct-
ive disease (FEV1/FVC <70%) or decreased diffusion cap-
acity (DLCO/VA <80%) were considered abnormal. All
patients had tuberculin test, chest x-ray and punch or
wedge biopsy of the skin. Chest roentgenograms were
staged as follows: stage 0: normal, stage 1: bilateral hilar
lymphadenopathy (BHL), stage 2: BHL and parenchymal
involvement, stage 3: parenchymal involvement only and
stage 4: pulmonary fibrosis [8]. Serum Angiotensin
Converting Enzyme (ACE), chest CT and BAL were
performed in 74 (61.6%), 71 (58.3%) and 54 (45%) of
the patients, respectively.
For the bronchoalveolar lavage, the fiberoptic broncho-
scope was wedged into a subsegmental bronchus of themiddle lobe or lingula after routine inspection of the tra-
cheobronchial tree. Prewarmed 0.9% saline solution to
37°C in five 20 ml aliquots up to a total volume of 100 ml
was infused into the subsegmental bronchus and at least
40 ml or 40% of the infused volume was recovered back.
After mucus removal BAL sample was cytocentrifugated
for examination. The slides were stained with Giemsa or
hematoxylin-eosin. A differential cell count was per-
formed on at least 300 non-epithelial cells.
Skin punch biopsy was done on the site with the most
advanced inflammatory changes. Isopropyl alcohol or
providone-iodine was used as a skin antiseptic to prepare
the biopsy site. Lidocaine 2% was applied for local
anesthesia. Biopsies were performed with disposable
knives of 4–6 mm in diameter. Punches no more than 5
mm were done for biopsy. Incisional wedge biopsy was
performed in patients with nondiagnostic punch biopsy
results. The histopathologic changes in specific skin
lesions consisted of dermal nests, clusters of noncaseating
epithelioid granulomas with minimal inflammatory cells,
and variable giant cells. Necrobiotic collagen and necrosis
were absent with sparse lymphocytic infiltrate concen-
trated peripherally around the noncaseating granulomas.
Thirty-two (26.6%) patients were treated with methyl-
prednisolone 0.25-0.50 mg/kg for at least 12 months.
Azathioprine 2 mg/kg was commenced in 9 (7.5%) pa-
tients unresponsive to steroid treatment.
For statistical analysis of the data, chi-square and stu-
dent’s t test were used. Correlation between radiologic
involvement, serum ACE and pulmonary function was
determined by the application of Spearman rank test. A
p value less than 0.05 was considered as significant.
Results
All patients presented with various skin lesions at admis-
sion or during the course of the disease. Of the 120
cases 82 (68.3%) were women. The age ranged between
18 and 56 years and the mean age was 38.4 ± 11.6 years.
The distribution of skin lesions and the dermographic
features of the patients are shown in Table 1. Erythema
nodosum (EN) followed by maculopapular lesions was
the most frequent skin lesion. Comparison of clinical
and laboratory findings in regard to skin involvement is
shown in Table 2. Out of the 41 patients with abnormal
pulmonary function test results, 24 (20%) had restrict-
ive, 10 (8%) had mixed and 7 (5.8%) had obstructive
type of pulmonary function abnormality. Eighteen pa-
tients (15%) had diffusion impairment.
Punch biopsy was diagnostic in 98 (81.6%) patients
and incisional wedge biopsy was done in the remaining
ones to identify skin involvement. Eight patients
reported a minimal sense of pain during the procedure.
The major complications of punch biopsy were bleeding
and infection which occurred in 5 (4.1%) and 3 (2.5%)
Table 1 The frequency of skin lesions and the dermographic features
Type of lesion N. of patients (%) Age (mean ± SD) N. (%) of female patients
Erythema nodosum 25 (20.8%) 38.6 ± 8.4 19 (15.8%)
Lupus Pernio 21 (17.5%) 41.8 ± 9.2 12 (10%)
Maculopapular lesions 19 (15.8%) 40.3 ± 7.1 14 (11.6%)
Plaque 14 (11.6%) 42.6 ± 6.2 9 (7.5%)
Nodules 10 (8.3%) 36.9 ± 10.4 6 (5%)
Scar 8 (6.6%) 39.4 ± 5.3 7 (5.8%)
Verrucose outgrowths 7 (5.8%) 44.9 ± 14.1 5 (4.1%)
Subcutaneous lesions 6 (5%) 37.4 ± 11.2 3 (2.5%)
Ulcerative and vesicular lesions 5 (4.1%) 42.6 ± 8.3 3 (2.5%)
Ichthyosis 3 (2.5%) 39.4 ± 3.9 2 (1.6%)
Erythema multiforme 2 (1.6%) 38 ± 5.6 2 (1.6%)
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4%. Seventy-two patients (60%) had specific skin lesions
and they occurred more frequently in stages 2 and 3
while nonspecific lesions were more common in stage 0
and 1 (p < 0.001). In thirty-six (30%) patients, skin in-
volvement was the initial finding of sarcoidosis. Of these
patients, 12 had BAL lymphocytosis, 9 had high CD4/
CD8 ratio, 10 had elevated serum ACE levels, and 24
had specific cutaneous involvement (p < 0.05). Inflamma-
tory markers were normal in eight patients. Fifty-four
patients (45%) had dry, cough, dyspnea and chest dis-
comfort while 32 patients (26.6%) had systemic symp-
toms like fever, fatigue, malaise, arthralgia and the
remaining 16 patients (13.3%) had specific organ related
symptoms.
Out of the 74 patients with specific skin lesions, 47
63.5% had systemic involvement. Systemic diseaseTable 2 Comparison of clinical and laboratory findings
Clinical profile of 72 patients with specific
skin involvement (n, %)
Respiratory symptoms 50 (69.4%)
















BAL CD4/CD8 ratio (> 3.5) 28 (38.8%)
Chi square and Spearman rank correlation tests were used for the statistical analysi
NS, not statistically significant at p < 0.05.occurred in 29 patients (60.4%) with nonspecific skin in-
volvement. Although respiratory symptoms and other
organ involvement were less frequent in patients with
nonspecific skin lesions there was no significant differ-
ence (p < 0.32) between the two groups in terms of sys-
temic disease. High CD4/CD8 ratio, high intensity
alveolitis (T-cell percentage > 28%) and elevated serum
ACE levels were significantly more common in patients
with specific cutaneous involvement (p < 0.01) (Table 2).
BAL lymphocytosis and high CD4/CD8 ratio correlated
with high serum ACE levels (r = 0.64, r = 0.76, p < 0.001).
In stage 0 patients with skin lesions as the initial finding,
six had BAL lymphocytosis, four had high CD4/CD8 ra-
tio, and three had abnormal ACE levels (p < 0.32). Levels
of liver function test, serum and urinary calcium were
not significantly different between patients with speci-
fic and nonspecific cutaneous involvement (p < 0.46)Clinical profile of 48 patients with nonspecific










14 (29.1%) r = 0.76, p < 0.05
11 (22.9%) r = 0.72, p < 0.01
10 (20.8%) r = 0.70, p < 0.05
s of data.
















41 (89.1%) 5 (10.8%) p < 0.01
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tients. Chest roentgenogram analysis revealed a statisti-
cally significant trend among patients with specific skin
lesions (p < 0.01) in regard to disease stage (Table 3).
The most frequent CT findings were widespread nodules
distributed among the bronchovascular bundles or
subpleurally followed by interstititial infiltrates, hilar and
mediastinal adenopathy, consolidation and architectural
distortion with fibrotic changes of the lung parenchyma.
The correlation between widespread nodules and the
specific lesions was high (r = 0.82, p < 0.05). Interstitital
infiltrates were more common in patients with non-
specific cutaneous lesions (r = 0.71, p < 0.05).
The features for progressive disease were manifestation
of new systemic or organ related symptoms, progression
of previous symptoms, deterioration of pulmonary func-
tion tests and/or radiologic findings. The frequency of pro-
gressive disease was more significant (p < 0.05) in patients
with specific cutaneous lesions (Table 4). Patients with
erythema nodosum had the best prognosis (p < 0.001).
There was no correlation between BAL lymphocytosis or
high CD4/CD8 ratio and pulmonary function test results
and DLCO (r = 0.24, p < 0.05; r = 0.18, p < 0.05).
The mean follow up time was 11.8 years. Fifty-eight
percent of stage I patients had spontaneous resolution
while the remaining ones progressed to stage II. Forty
eight percent of these patients progressed to stage III. In
stage III, 58% resolved while 18% progressed to stage
IV disease. Following immunosuppressive treatment,
the elevated serum ACE levels decreased significantly
(p < 0.05) in patients with specific cutaneous lesions. In
patients with nonspecific skin involvement, correlation
of treatment and serum ACE decrease was not signifi-
cant. Mortality rate was 15% (18 patients) and in 10 pa-
tients it was due to causes other than sarcoidosis. Four
patients died of respiratory insufficiency and 5 patients
died of sudden heart attack.
Discussion
Sarcoidosis is a systemic granulomatous disease of un-
known origin that can affect any organ in the body. TheTable 3 Distribution of patients with specific and
nonspecific cutaneous involvement according to the
stage of sarcoidosis
Stage N. of patients with specific
skin involvement (%)
N. of patients with nonspecific
skin involvement (%)
0 7 (5.8%) 9 (7.5%)
I 28 (23.3%) 22 (18.3%)
II 21 (17.5%) 10 (8.3%)
III 12 (10%) 4 (3.3%)
IV 6 (5%) 1 (0.83%)lungs, eyes, skin, liver, and lymphatic system are most
commonly involved. Skin lesions may appear at any
stage of the disease and specific skin lesions may occur
in 9% to 37% of the patients [4,5]. Lesions often appear
at the onset of systemic illness, providing a valuable op-
portunity for early diagnosis [9,10]. Cutaneous sarcoid-
osis may develop with or without systemic involvement.
Because the skin lesions may present with a wide
spectrum of different morphologies, sarcoidosis becomes
a diagnostic challenge for the internist, especially when
the lesions are nonspecific or when there is no systemic
involvement [11,12]. The purpose of our study was
to determine the association between specific or non-
specific skin lesions and involvement of other organ
systems, laboratory findings, disease course, and to dem-
onstrate the diagnostic yield of punch biopsy in cutane-
ous sarcoidosis.
Cutaneous sarcoidosis was the initial manifestation in
approximately one third of our patients and was a com-
patible finding with the literature data [4,5]. BAL lym-
phocytosis, high CD4/CD8 ratio, and elevated serum
ACE levels in this group may be considered as important
laboratory markers for the diagnosis of sarcoidosis. Al-
though not statistically significant, BAL lymphocytosis,
particularly with a high CD4/CD8 ratio, and an elevated
serum ACE, were highly suggestive of sarcoidosis in the
context of nonspecific cutaneous involvement with no
other systemic findings. The decreased frequency of re-
spiratory symptoms, systemic involvement and lack of
laboratory abnormalities were more common in patients
with erythema nodosum. On the other hand, BAL lym-
phocytosis, high CD4/CD8 ratio, and elevated serum
ACE levels were significantly more frequent in patients
with specific skin lesions. These laboratory findings may
be associated with the granulomatous burden of the spe-
cific skin lesions. Activated T cells and macrophages in
specific cutaneous lesions release a number of cytokines
that cause progressive disease.
Skin involvement in females were approximately two
times more than males. This is probably due to estrogen
that may play a role in the development of skin lesions
[13]. Another factor is the failure of every patient to
undergo a routine dermatologic examination. This may
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greater tendency than males to observe their body or
skin for these type of lesions.
There was no significant difference in the frequency
of laboratory abnormalities, except the high frequency
of negative tuberculin test in patients with specific skin
lesions. The presence of abnormal pulmonary function
tests, ocular, and neurological involvement was not sig-
nificantly different between patients with specific and
nonspecific cutaneous involvement but was more com-
mon in the former. The trend toward radiologically
more advanced disease was more frequent in patients
with specific skin disease along with BAL lymphocyto-
sis, high CD4/CD8 ratio and an elevated serum ACE
level. Definitive correlations between specific histopath-
ologic features and clinical disease have not been dem-
onstrated to date. Hanno and Mana have reported that
specific skin lesions usually have no prognostic signifi-
cance, do not show any correlation with the extent of
systemic involvement and do not indicate a more ser-
ious form of sarcoidosis [9,12]. Our findings contradict
the results of these studies, but the the sample size of
our study is much greater than that in the others.
However, Olive has noted that patients with skin lesions
are more likely to have systemic involvement which
supports our results [4]. The frequency of cutaneous in-
volvement and particular types of skin lesions of sar-
coidosis vary across different races or regions [14,15]. In
addition to sarcoidosis being more frequent in individ-
uals of Afro-American origin, skin involvement in these
individuals may also have a more severe form [16].
Ethnic differences may play an important role for skin
and systemic involvement as well as progressive disease.
Our patient population included had a very wide ethnic
base and it was almost impossible to identify the ethnic
origin. They were followed up at least for five years after
the initial diagnosis and are currently under control.
The minimum six years follow-up is a sufficient period
of time for a medical prognosis of sarcoidosis in regard
to cutaneous involvement. Our findings are statistically
significant but they may not be clinically significant.
Further studies with larger populations are needed to
discriminate clinical and prognostic differences between
patients with specific and nonspecific cutaneous lesions
in sarcoidosis.
A recognition of cutaneous lesions is important be-
cause they provide a visible clue to diagnosis especially if
they have a specific appearance. These lesions also are
an easily accessible source of tissue for diagnosis. Punch
biopsy provided sufficient tissue for histopathologic
examination, was diagnostic of both sarcodosis and
sarcoidosis associated cutaneous lesions in most of our
patients. In the remaining patients, histopathological
examination of the incisional wedge biopsy confirmedthe diagnosis. We believe that punch biopsy is a simple
technique to learn and it can easily be performed for cu-
taneous sarcoidosis with high a diagnostic yield and a
low rate of complications. As the clinician becomes
more experienced with the technique, the diagnostic ac-
curacy will increase because most of the nondiagnostic
punch biopsy results were the initial biopsies.Conclusion
In conclusion, our results suggest that the presence of
noncaseating granulomas on skin biopsy along with BAL
lymphocytosis, a high CD4/CD8 ratio, and an elevated
serum ACE level are associated with progressive disease.
Cutaneous involvement in sarcoidosis is not only useful
for diagnosis but may also discriminate progressive dis-
ease. Specific lesions like lupus pernio and plaques may
have a prognostic significance. Punch biopsy is a simple
and accurate technique that can be easily performed for
the diagnosis of sarcoidosis itself and the associated cu-
taneous lesions.
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